F-group (family)
5051.1.1.3 SSF
Ligands and drugs
340
Member domains
36
with ligand contacts (≤ 4 Å)
10.6% of members
24
with DrugDomain annotations
7.1% of members
14
with a DrugBank compound
4.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5051.1.1.3 belongs to X-group 5051 Sodium:neurotransmitter symporter family (SNF)-like, which binds 11.5 ligand superclasses per 20 proteins, broader than 99% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 5 |
| DB04265 | SLB | N-acetyl-beta-neuraminic acid | 2 |
| DB12713 | LFL | Sotagliflozin | 2 |
| DB00166 | — | Lipoic acid | 1 |
| DB03568 | BUA | Butyric Acid | 1 |
| DB03796 | PLM | Palmitic Acid | 1 |
| DB04540 | CLR | Cholesterol | 1 |
| DB05382 | — | Iodine | 1 |
| DB06292 | LE6 | Dapagliflozin | 1 |
| DB08907 | L3R | Canagliflozin | 1 |
| DB09038 | 7R3 | Empagliflozin | 1 |
| DB09418 | — | — | 1 |
| DB11827 | — | — | 1 |
| DB16771 | LN9 | Phlorizin | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAmetal | SODIUM ION | 19 |
| HC6 | (2S,2'S)-2,2'-biphenyl-4,4'-diylbis(2-hydroxy-4,4-dimethylmorpholin-4-ium) | 5 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 5 |
| CHT | CHOLINE ION | 4 |
| ER3metal | ERBIUM (III) ION | 4 |
| GAL | beta-D-galactopyranose | 4 |
| Y01 | CHOLESTEROL HEMISUCCINATE | 4 |
| 3PH | 1,2-DIACYL-GLYCEROL-3-SN-PHOSPHATE | 3 |
| CL | CHLORIDE ION | 3 |
| A1AOW | 4-methoxy-3-[(1-methylpiperidin-4-yl)oxy]-N-{[3-(propan-2-yl)-1,2-oxazol-5-yl]methyl}benzamide | 2 |
| A1EFW | (2~{S},3~{R},4~{R},5~{S},6~{R})-5-fluoranyl-6-(hydroxymethyl)oxane-2,3,4-triol | 2 |
| AV0 | Lauryl Maltose Neopentyl Glycol | 2 |
| R16 | HEXADECANE | 2 |
| REO | PERRHENATE | 2 |
| SLB | N-acetyl-beta-neuraminic acid | 2 |
| 1YI | N-[2-(dimethylamino)ethyl]-2-methyl-2-[4-[4-[[2-methyl-5-[(2S,3R,4R,5S,6R)-6-methylsulfanyl-3,4,5-tris(oxidanyl)oxan-2-yl]phenyl]methyl]phenyl]butanoylamino]propanamide | 1 |
| 7R3 | (2S,3R,4R,5S,6R)-2-[4-chloranyl-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol | 1 |
| BUA | butanoic acid | 1 |
| CLR | CHOLESTEROL | 1 |
| GYP | methyl alpha-D-glucopyranoside | 1 |